These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 18804405

  • 1. Ribonucleotide reductase small subunit p53R2 promotes oral cancer invasion via the E-cadherin/beta-catenin pathway.
    Yanamoto S, Kawasaki G, Yamada S, Yoshitomi I, Yoshida H, Mizuno A.
    Oral Oncol; 2009 Jun; 45(6):521-5. PubMed ID: 18804405
    [Abstract] [Full Text] [Related]

  • 2. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
    Liu X, Zhou B, Xue L, Shih J, Tye K, Lin W, Qi C, Chu P, Un F, Wen W, Yen Y.
    Clin Cancer Res; 2006 Nov 01; 12(21):6337-44. PubMed ID: 17085643
    [Abstract] [Full Text] [Related]

  • 3. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
    Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, Sato S, Miyauchi M, Takata T.
    Clin Cancer Res; 2004 Aug 15; 10(16):5455-63. PubMed ID: 15328184
    [Abstract] [Full Text] [Related]

  • 4. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
    Ghosh S, Munshi HG, Sen R, Linz-McGillem LA, Goldman RD, Lorch J, Green KJ, Jones JC, Stack MS.
    Cancer; 2002 Dec 15; 95(12):2524-33. PubMed ID: 12467066
    [Abstract] [Full Text] [Related]

  • 5. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
    Liu X, Zhou B, Xue L, Yen F, Chu P, Un F, Yen Y.
    Clin Colorectal Cancer; 2007 Jan 15; 6(5):374-81. PubMed ID: 17311703
    [Abstract] [Full Text] [Related]

  • 6. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
    Matsushita S, Ikeda R, Fukushige T, Tajitsu Y, Gunshin K, Okumura H, Ushiyama M, Akiyama S, Kawai K, Takeda Y, Yamada K, Kanekura T.
    J Dermatol Sci; 2012 Oct 15; 68(1):19-24. PubMed ID: 22902076
    [Abstract] [Full Text] [Related]

  • 7. Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma.
    Yanamoto S, Kawasaki G, Yoshitomi I, Mizuno A.
    Cancer Lett; 2003 Feb 20; 190(2):233-43. PubMed ID: 12565178
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF.
    Mol Cell Biol; 2007 Nov 20; 27(21):7703-17. PubMed ID: 17785436
    [Abstract] [Full Text] [Related]

  • 14. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep 20; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells.
    Yanamoto S, Iwamoto T, Kawasaki G, Yoshitomi I, Baba N, Mizuno A.
    Cancer Lett; 2005 Jun 01; 223(1):67-76. PubMed ID: 15890238
    [Abstract] [Full Text] [Related]

  • 17. Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line.
    Supriatno, Harada K, Kawaguchi S, Yoshida H, Sato M.
    Oncol Rep; 2003 Jun 01; 10(3):527-32. PubMed ID: 12684618
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.